Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters

Life Sciences

Volumn 89, Issue 1-2, 2011, Pages 57-64

  Ghose, Romi ^a   Omoluabi, Ozozoma ^a   Gandhi, Adarsh ^a   Shah, Pranav ^a   Strohacker, Kelley ^a   Carpenter, Katie C ^a   McFarlin, Brian ^a   Guo, Tao ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Drug metabolism; Nuclear receptors; Obesity

Indexed keywords

CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 2A; CYTOCHROME P450 2A4; CYTOCHROME P450 2B; CYTOCHROME P450 2B 10; CYTOCHROME P450 3A11; DRUG METABOLIZING ENZYME; ENZYME; GLUCURONOSYLTRANSFERASE 1A1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MIDAZOLAM; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1B; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; PREGNANE X RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; SULFOTRANSFERASE 1A1; SULTN ENZYME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZOXAZOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; LIPID DIET; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OBESITY; SLEEP TIME;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; ARYLSULFOTRANSFERASE; CYTOCHROME P-450 CYP3A; CYTOKINES; DIETARY FATS; ENZYMES; GENE EXPRESSION REGULATION; GLUCURONOSYLTRANSFERASE; IMMUNOBLOTTING; LIVER; MALE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MIDAZOLAM; NF-KAPPA B; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SLEEP; STEROID HYDROXYLASES; ZOXAZOLAMINE;

MUS;

EID: 79959372084     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.05.005     Document Type: Article

References (44)

1. Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol 2006;46:123-49. (Pubitemid 43271186)
2. Blouin RA, Warren GW. Pharmacokinetic considerations in obesity. J Pharm Sci 1999;88(1):1-7. (Pubitemid 29037361)
3. Braun L, Coffey MJ, Puskas F, Kardon T, Nagy G, Conley AA, et al. Molecular basis of bilirubin UDP-glucuronosyltransferase induction in spontaneously diabetic rats, acetone-treated rats and starved rats. Biochem J 1998;336(Pt 3):587-92. (Pubitemid 29008016)
4. Breslin WL, Strohacker K, Carpenter KC, Esposito L, McFarlin BK. Weight gain in response to high-fat feeding in CD-1 male mice. Lab Anim 2010;44(3):231-7.
5. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005;11(2):183-90. (Pubitemid 40321354)
6. Chen C, Staudinger JL, Klaassen CD. Nuclear receptor, pregnane X receptor is required for induction of UDP-glucoronosyltransferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab Dispos 2003;31(7):908-15. (Pubitemid 36759061)
7. Chen M, Xu D, Hu XL, Wang H. Effects of liver fibrosis on verapamil pharmacokinetics in rats. Clin Exp Pharmacol Physiol 2008;35(3):287-94. (Pubitemid 351257881)
8. Cheng Q, Aleksunes LM, Manautou JE, Cherrington NJ, Scheffer GL, Yamasaki H, et al. Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. Mol Pharm 2008;5(1):77-91. (Pubitemid 351300037)
9. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet 2000;39(3):215-31.
10. Chia R, Achilli F, Festing MF, Fisher EM. The origins and uses of mouse outbred stocks. Nat Genet 2005;37(11):1181-6. (Pubitemid 41568697)
11. Collins S, Martin TL, Surwit RS, Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6 J mouse: physiological and molecular characteristics. Physiol Behav 2004;81(2):243-8.
12. Ghose R, Zimmerman TL, Thevananther S, Karpen SJ. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2004;2(1):4.
13. Ghose R, Mulder J, von Furstenberg RJ, Thevananther S, Kuipers F, Karpen SJ. Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver. J Hepatol 2007;46(1):115-23. (Pubitemid 44827424)
14. He P, Court MH, Greenblatt DJ, von Moltke LL. Factors influencing midazolam hydroxylation activity in human liver microsomes. Drug Metab Dispos 2006;34(7): 1198-207.
15. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature 2002;420(6913):333-6. (Pubitemid 35398190)
16. Irizar A, Barnett CR, Flatt PR, Ioannides C. Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rat. Eur J Pharmacol 1995;293(4):385-93. (Pubitemid 3006681)
17. Itoh M, Adachi M, YasuiH, TakekawaM, TanakaH, Imai K.Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol 2002;16(10):2382-92.
18. Khemawoot P, Yokogawa K, Shimada T, Miyamoto K. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats. Biochem Pharmacol 2007;73(1):155-62. (Pubitemid 44853929)
19. Kim S, Sohn I, Ahn JI, Lee KH, Lee YS, Lee YS. Hepatic gene expression profiles in a longterm high-fat diet-induced obesity mouse model. Gene 2004;340(1):99-109. (Pubitemid 39360236)
20. Leclercq IA, Field J, Enriquez A, Farrell GC, Robertson GR. Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. Biochem Biophys Res Commun 2000;268(2):337-44. (Pubitemid 30119623)
21. Liang HC, Li H, McKinnon RA, Duffy JJ, Potter SS, Puga A, et al. Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. Proc Natl Acad Sci U S A 1996;93(4):1671-6. (Pubitemid 26075183)
22. Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification.Mol Pharmacol 2002;62(3): 638-46.
23. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;83(6): 841-50. (Pubitemid 26006526)
24. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83(6):835-9.
25. McFarlin BK, Strohacker KA, Kueht ML. Pomegranate seed oil consumption during a period of high-fat feeding reduces weight gain and reduces type 2 diabetes risk in CD-1 mice. Br J Nutr 2009;102(1):54-9.
26. Olkkola KT, Ahonen J. Midazolam and other benzodiazepines. Handb Exp Pharmacol 2008;182:335-60.
27. Osabe M, Sugatani J, Fukuyama T, Ikushiro S, Ikari A, Miwa M. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferatoractivated receptor alpha in male rats fed a high-fat and high-sucrose diet. Drug Metab Dispos 2008;36(2):294-302. (Pubitemid 351185741)
28. Pascussi JM, Gerbal-Chaloin S, Pichard-Garcia L, Daujat M, Fabre JM, Maurel P, et al. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun 2000;274(3):707-13. (Pubitemid 30663683)
29. Pascussi JM, Dvorak Z, Gerbal-Chaloin S, Assenat E, Maurel P, Vilarem MJ. Pathophysiological factors affecting CAR gene expression. Drug Metab Rev 2003;35(4):255-68. (Pubitemid 38018105)
30. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol 2001;13(7): 777-84. (Pubitemid 32656590)
31. Rochette-Egly C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell Signal 2003;15(4):355-66. (Pubitemid 36254908)
32. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116(7):1793-801. (Pubitemid 44033299)
33. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132(6):2169-80. (Pubitemid 46693756)
34. Staudinger JL, Lichti K. Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease. Mol Pharm 2008;5(1):17-34. (Pubitemid 351300031)
35. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6 J mice. Diabetes 1988;37(9):1163-7.
36. Tan Z, Huang M, Puga A, Xia Y. A critical role for MAP kinases in the control of Ah receptor complex activity. Toxicol Sci 2004;82(1):80-7. (Pubitemid 39485322)
37. Teng S, Piquette-Miller M. Regulation of transporters by nuclear hormone receptors: implications during inflammation. Mol Pharm 2008;5(1):67-76. (Pubitemid 351300036)
38. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, et al. Dietinduced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997;99(3):385-90. (Pubitemid 27414794)
39. Wang T, Shankar K, Ronis MJ, Mehendale HM. Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes. Crit Rev Toxicol 2007;37(5):413-59. (Pubitemid 47035211)
40. Wei P, Zhang J, Egan-Hafley M, Liang S, Moore DD. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000;407(6806):920-3.
41. Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med 2005;352(21):2211-21.
42. Yang CS, Brady JF, Hong JY. Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity. FASEB J 1992;6(2):737-44.
43. Yoshinari K, Takagi S, Yoshimasa T, Sugatani J, Miwa M. Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet. Pharm Res 2006;23(6):1188-200. (Pubitemid 43946141)
44. Zimmerman TL, Thevananther S, Ghose R, Burns AR, Karpen SJ. Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem 2006;281(22):15434-40. (Pubitemid 43855135)